Myomo Inc. found using ticker (MYO) have now 4 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 16 and 11.25 with a mean TP of 13.81. Now with the previous closing price of 12.84 this would imply there is a potential upside of 7.6%. The day 50 moving average is 9.75 and the 200 day MA is 6.03. The market capitalisation for the company is $59m. Company Website: http://www.myomo.com
Myomo, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace orthosis product used for supporting a patient’s weak or paralyzed arm to enable and enhance functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and distributors. Myomo was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.